Kunxiangda's Molecular Mastery: 6-Amino-1,3-Dimethyluracil

In the world of pharmaceuticals, the difference between a successful drug and a failed one often lies in the precision of its building blocks—pharmaceutical intermediates. These specialized chemicals are the backbone of drug synthesis, requiring molecular-level accuracy to ensure safety, efficacy, and consistency. For Shijiazhuang Kunxiangda Technology Co., Ltd., mastering these building blocks isn’t just a business—it’s a commitment to advancing global healthcare. Among their portfolio of high-quality intermediates, 6-Amino-1,3-Dimethyluracil (DMAU) stands out as a testament to their “molecular mastery”: a versatile, high-purity compound that powers everything from life-saving drugs to industrial stabilizers. Since 2011, Kunxiangda has grown from a local manufacturer to a global leader in bulk pharmaceutical intermediates, leveraging university collaborations, advanced production, and a customer-centric approach to redefine what’s possible in fine chemical manufacturing.

Kunxiangda’s Pharmaceutical Intermediates Legacy: 13 Years of Precision 

Shijiazhuang Kunxiangda Technology Co., Ltd. was founded in 2011 with a clear mission: to fill the gap for reliable, high-quality pharmaceutical intermediates in China and beyond. At the time, the global pharmaceutical industry struggled with inconsistent intermediate supplies—batch-to-batch variations that delayed drug development and increased regulatory risks. Kunxiangda set out to solve this by focusing on two core principles: technical excellence and customer trust.

Today, the company’s 50-acre factory in Shijiazhuang’s Economic and Technological Development Zone is a hub of innovation, employing over 300 people (including 9 dedicated technical staff) and producing a full range of intermediates, from 1,3-dimethylurea (DMU) to 6-Amino-1,3-Dimethyluracil (DMAU). What sets Kunxiangda apart is its refusal to cut corners: it partners with Tsinghua University and Hebei University of Science and Technology to refine production processes, ensuring its pharmaceutical intermediates meet the strictest global standards (including EU-REACH registration for DMAU). Over 13 years, Kunxiangda has built a mature global marketing network, exporting to Europe, South America, and the Middle East, and earning a reputation as a “reliable partner” for both small labs and large pharmaceutical firms. For Kunxiangda, pharmaceutical intermediates aren’t just chemicals—they’re a promise to improve lives through better medicine.

6-Amino-1,3-Dimethyluracil: Kunxiangda’s Molecular Masterpiece 

6-Amino-1,3-Dimethyluracil (DMAU) is Kunxiangda’s flagship product, a compound that showcases the company’s ability to balance versatility, purity, and scalability. As a leading manufacturer of DMAU, Kunxiangda has optimized every aspect of its production, from molecular structure to application, making it a top choice for both pharmaceutical and industrial clients. Below is a detailed breakdown of DMAU’s key parameters and why it’s a “molecular masterpiece”:

Kunxiangda’s DMAU shines in pharmaceutical applications: Theophylline, a drug used to treat asthma and chronic obstructive pulmonary disease (COPD), relies on DMAU as a key intermediate. Kunxiangda’s DMAU ensures the drug is synthesized with uniform potency, so patients get the same effective dose every time. In industry, its use as a PVC heat stabilizer means longer-lasting, safer plastic products—from medical devices to construction materials. This dual impact is what makes DMAU more than just an intermediate; it’s a compound that connects healthcare and daily life.

Bulk Pharmaceutical Intermediates: Kunxiangda’s Scalable Excellence 

For pharmaceutical companies producing drugs at scale, bulk pharmaceutical intermediates are non-negotiable—and Kunxiangda excels at delivering consistent quality in large quantities. Unlike small-batch manufacturers, Kunxiangda has invested in scalable production lines that can meet the demands of global pharmaceutical firms, all while maintaining the precision that defines its products.

Take 6-Amino-1,3-Dimethyluracil (DMAU) as an example: Kunxiangda’s factory is equipped to produce DMAU in bulk, with a supply chain that ensures raw material consistency (thanks to its professional procurement team) and packaging that preserves quality during transit (25kg/bags, optimized for 20FCL containers). For a pharmaceutical company making millions of Theophylline tablets yearly, this scalability means no production delays—even during peak demand. Kunxiangda also offers flexible bulk ordering, allowing clients to adjust quantities based on their needs, and provides technical support to help integrate its bulk pharmaceutical intermediates into existing production lines.

What truly sets Kunxiangda’s bulk intermediates apart is their quality-to-cost ratio. By partnering with universities to optimize processes, Kunxiangda has reduced production costs without compromising purity—making its bulk pharmaceutical intermediates accessible to both large firms and emerging drug developers. This commitment to scalable excellence is why Kunxiangda is trusted by clients worldwide: they know that whether they order 1 ton or 100 tons of DMAU, every batch will meet the same high standards.

FAQs: Pharmaceutical Intermediates, DMAU & Bulk Supplies

Pharmaceutical intermediates: EU-REACH certified? 

Yes! Key pharmaceutical intermediates like DMAU have EU-REACH registration, enabling seamless export to European markets and meeting strict regulatory requirements.

6-Amino-1,3-Dimethyluracil for Theophylline?

Absolutely. Kunxiangda’s 6-Amino-1,3-Dimethyluracil is a core intermediate for Theophylline, with high purity ensuring consistent drug potency.

Bulk pharmaceutical intermediates: Flexible supply?

Yes. Kunxiangda offers flexible bulk orders for bulk pharmaceutical intermediates, adjusting quantities to match client production needs.

6-Amino-1,3-Dimethyluracil: Industrial use?

Yes. It works as a PVC heat stabilizer, enhancing plastic durability for industrial and medical applications.

Why choose Kunxiangda for pharmaceutical intermediates?

Choose Kunxiangda for 13 years of expertise, university-backed R&D, EU-REACH certified pharmaceutical intermediates (including DMAU), and scalable bulk supplies—all backed by reliable service.

Kunxiangda’s “molecular mastery” isn’t just about making chemicals—it’s about making a difference. From the precision of 6-Amino-1,3-Dimethyluracil that powers life-saving asthma drugs to the scalability of its bulk pharmaceutical intermediates that keep global drug production on track, every product reflects the company’s ethos: “Harmony, integrity, development, win-win.” For pharmaceutical firms, industrial clients, and innovators worldwide, Kunxiangda isn’t just a supplier—it’s a partner in advancing health and industry through molecular excellence. In Shijiazhuang, and across the globe, Kunxiangda’s mastery is redefining what’s possible with pharmaceutical intermediates.